Christopher Ehinger of Black Swan Analysis explores one of the key trends in the pharma industry at the moment: defining patient populations. He believes that in order to be successful in the...
Black Swan Analysis Blog
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem.
Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharma forecasting.
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast
*In the run up to Forecasting Europe  in Berlin in June, eyeforpharma asked some of our key speakers for their ins*  http://www.eyeforpharma.com/forecastingeu/
Peter Mansell explores how pharmaceutical forecasters are developing new methods and new metrics to enable them to make better guesses
Participants in a roundtable discussion at eyeforpharmas recent Pharmaceutical Forecasting Excellence Summit 2009 took a look at pharmas interest in entering emerging markets such as Brazil, Russia,...